Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & Administrative
Others
Ratios

Bone Biologics (BBLGW) Shares Outstanding (Weighted Average) (2016 - 2017)

Bone Biologics (BBLGW) has disclosed Shares Outstanding (Weighted Average) for 2 consecutive years, with $38.9 million as the latest value for Q3 2017.

  • Quarterly Shares Outstanding (Weighted Average) changed 0.15% to $38.9 million in Q3 2017 from the year-ago period, while the trailing twelve-month figure was $38.9 million through Sep 2017, changed 0.15% year-over-year, with the annual reading at $37.6 million for FY2016, N/A changed from the prior year.
  • Shares Outstanding (Weighted Average) for Q3 2017 was $38.9 million at Bone Biologics, roughly flat from $38.8 million in the prior quarter.
  • The five-year high for Shares Outstanding (Weighted Average) was $38.9 million in Q3 2017, with the low at $34.7 million in Q1 2016.